Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) has gained widespread attention for weight loss, but many patients seek alternatives due to cost, availability, or personal preference. Compounded semaglutide and tirzepatide work through identical biological mechanisms and can produce comparable weight reduction when dosed appropriately. PlexusDx connects patients with licensed 503A compounding pharmacies offering these medications at transparent, flat monthly prices—no dose-based billing.

How Semaglutide and Tirzepatide Work for Weight Loss

Both semaglutide and tirzepatide activate GLP-1 receptors in the brain and gut, signaling fullness and reducing hunger. Semaglutide is a GLP-1 receptor agonist alone, while tirzepatide activates both GLP-1 and GIP receptors—a dual mechanism that may enhance satiety and metabolic effects. Clinical trials show semaglutide produces 15–22% body weight reduction over 68 weeks, while tirzepatide achieves 20–22% reduction at higher doses.

The appetite-suppressing effect occurs within days to weeks of starting therapy. Patients typically report eating smaller portions, reduced food cravings, and sustained fullness lasting several hours after meals. This biological shift in hunger signaling addresses the root cause of weight regain rather than relying on willpower alone, making these medications particularly effective for individuals with obesity-related metabolic dysfunction.

Compounded Semaglutide vs. Brand-Name Ozempic

Compounded semaglutide contains the same active ingredient as brand-name Ozempic but is manufactured by licensed 503A compounding pharmacies rather than pharmaceutical manufacturers. Both formulations are FDA-regulated semaglutide; compounded versions simply bypass high brand markups and patent protections. PlexusDx sources all compounded medications from licensed 503A pharmacies, ensuring pharmaceutical-grade purity and sterility standards.

The key difference is cost and accessibility. Brand Ozempic often costs $900–$1,300 monthly without insurance, while PlexusDx compounded semaglutide injection starts at $149 per month with a flat pricing structure—meaning dose increases do not trigger price increases. Both options deliver identical clinical outcomes when dosed appropriately by a licensed healthcare provider.

Tirzepatide as a Dual-Action Alternative

Tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, offering a pharmacologically distinct mechanism compared to semaglutide alone. In clinical trials, this dual agonism produced greater A1C reduction and weight loss than semaglutide monotherapy in direct comparison studies. For patients seeking maximum metabolic benefit, tirzepatide may offer superior outcomes.

PlexusDx offers both compounded tirzepatide injection (starting at $249/month) and oral formulations. Tirzepatide injection typically requires weekly dosing, matching the convenience profile of semaglutide. The dual-receptor approach particularly benefits patients with insulin resistance or metabolic syndrome alongside obesity, as GIP activation enhances insulin secretion and glucose control.

Personalized Dosing Through Genetic Testing

Individual responses to GLP-1 and GLP-1/GIP therapy vary significantly based on genetic variation in appetite-regulation pathways. PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and 49 peptides relevant to weight regulation and medication response. Key variants like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 influence how patients respond to semaglutide and tirzepatide dosing.

Understanding your genetic profile helps PlexusDx providers optimize starting doses and titration schedules, reducing side effects while maximizing weight loss. Patients with certain genetic predispositions may respond better to semaglutide, while others achieve superior outcomes with tirzepatide. The Precision Peptide Genetic Test is available as a $99 add-on after the first month of treatment, enabling truly precision-guided therapy rather than trial-and-error dosing.

Cost-Effective Access Across All 50 States

PlexusDx compounded semaglutide and tirzepatide are available nationwide without insurance requirements or membership fees. All medications are HSA- and FSA-eligible, allowing patients to use tax-advantaged healthcare savings. The flat monthly pricing model—$149/month for semaglutide injection, $249/month for tirzepatide injection—eliminates surprise increases as doses climb, maintaining transparent, predictable costs.

Licensed 503A compounding pharmacies can prepare these medications in multiple formulations: injectable weekly doses, oral tablets, or microdose protocols for patients sensitive to standard dosing. PlexusDx's Microdose GLP-1 Protocol starts at just $129 per month, offering an entry point for patients beginning their weight loss journey or those requiring lower initial doses.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as safe as brand-name Ozempic?

Yes. Compounded semaglutide contains identical active semaglutide, prepared by licensed 503A compounding pharmacies under FDA oversight and sterility standards. Safety depends on proper dosing and medical supervision, not manufacturing source. PlexusDx medications are prescribed and monitored by licensed healthcare providers following the same protocols as brand medications.

What is the difference between semaglutide and tirzepatide for weight loss?

Semaglutide is a single GLP-1 receptor agonist producing 15–22% weight loss. Tirzepatide activates both GLP-1 and GIP receptors, achieving 20–22% weight loss with potentially greater metabolic benefits. Clinical trials show tirzepatide slightly outperforms semaglutide in head-to-head comparison, though individual responses vary. Your genetic profile and medical history help determine which is optimal for you.

How much does PlexusDx compounded semaglutide cost monthly?

Compounded semaglutide injection from PlexusDx starts at $149 per month, with flat pricing across all dose levels—your dose may increase, but your price does not. All medications are HSA/FSA-eligible and available nationwide without insurance or membership fees.

What side effects should I expect from semaglutide or tirzepatide?

Common side effects include nausea, vomiting, constipation, and diarrhea, typically mild and transient during the first 2–4 weeks. Microdose protocols and slow titration schedules minimize gastrointestinal effects. Rare serious risks include pancreatitis and medullary thyroid carcinoma; screening and medical supervision are essential. PlexusDx providers monitor you throughout treatment to manage side effects and adjust dosing as needed.

How does the Precision Peptide Genetic Test help with weight loss therapy?

The $99 Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 45 other peptide-pathway genes that influence appetite, satiety, and medication response. Results guide your provider in selecting semaglutide versus tirzepatide and optimizing your starting dose, increasing efficacy and reducing trial-and-error adjustments. Testing is available after your first month of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves